Gene · 8644
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis and cuproptosis in head and neck squamous cell carcinoma: interconnected mechanisms and therapeutic implications. | Front Pharmacol | 2026 | 41769686 | PubTator, text mining | PubMed |
| Current insights into monitoring of congenital adrenal hyperplasia. | Front Endocrinol (Lausanne) | 2026 | 41767372 | PubTator, text mining | PubMed |
| Directed C-H activation of 13α-estrone: a pathway to promising AKR1C inhibitors via docking and biological studies. | RSC Adv | 2026 | 41767230 | PubTator, text mining | PubMed |
| The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation. | Front Immunol | 2026 | 41756279 | PubTator, text mining | PubMed |
Comprehensive analysis of the deleterious nonsynonymous, non-coding SNPs and cancer variants of human aldo-keto reductase type 1 (AKR1C1) protein and their probable association with disease risk and progression: a computational study. | Biochem Biophys Rep | 2026 | 41756011 | PubTator, text mining | PubMed |
| DDX3 Regulates Reproduction in Locusta migratoria Potentially via Insulin/Insulin-like Growth Factor Signaling. | Insects | 2026 | 41752607 | PubTator, text mining | PubMed |
| DDX10 RNA Helicase: Structure, Function, and Oncogenic Roles Across Solid and Hematologic Tumors. | Genes (Basel) | 2026 | 41751522 | PubTator, text mining | PubMed |
| Environmental Lead Promotes Breast Cancer Migration and Invasion via the AKR1C3-NF-κB-MMP Axis. | Biomedicines | 2026 | 41751184 | PubTator, text mining | PubMed |
| Structural and Biophysical Analyses of Human Prostamide/Prostaglandin F Synthase with Two Active Form-Mimicking Mutations. | Biomolecules | 2026 | 41750332 | PubTator, text mining | PubMed |
| Correction: Govaerts et al. Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study. Cancers 2025, 17, 2425. | Cancers (Basel) | 2026 | 41749970 | PubTator, text mining | PubMed |
| Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features. | Curr Urol | 2026 | 41743916 | PubTator, text mining | PubMed |
| Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer. | Research (Wash D C) | 2026 | 41743623 | PubTator, text mining | PubMed |
Effect of Xiaonang Yusi decoction () on IVF outcomes in patients with phlegm-dampness type PCOS: a prospective cohort study with supporting metabolomics, network pharmacology, and molecular docking analysis. | Front Med (Lausanne) | 2026 | 41743096 | PubTator, text mining | PubMed |
| Cancer-Associated fibroblasts regulate the development of cholangiocarcinoma through IL-6/STAT3/AKR1C3 signaling axis. | Sci Rep | 2026 | 41735359 | PubTator, text mining | PubMed |
| DDX24 modulates angiogenesis by promoting CCR4-NOT complex-dependent mRNA decay. | Nucleic Acids Res | 2026 | 41728947 | PubTator, text mining | PubMed |
| Ferroptosis and immunity: rewiring the tumor microenvironment for therapy. | RSC Adv | 2026 | 41726230 | PubTator, text mining | PubMed |
| Lifestyle factors affecting the pathogenesis of androgenetic alopecia: a literature review. | Front Public Health | 2026 | 41717597 | PubTator, text mining | PubMed |
| Colorectal Cancer Organoid Model Reveals the Mechanisms of Irinotecan Resistance at Single-Cell Resolution. | Cancer Med | 2026 | 41678386 | PubTator, text mining | PubMed |
| Natural simple coumarins and their interaction with AKR1C3: implications for overcoming chemoradioresistance in gastrointestinal carcinomas. | Med Oncol | 2026 | 41665831 | PubTator, text mining | PubMed |
| Ferroptosis in glaucoma: Identification of key genes NR1D2 and AKR1C3 based on transcriptome bioinformatics analysis. | Medicine (Baltimore) | 2026 | 41630208 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8644/papers?page=3